首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.
【24h】

Bone marrow involvement in diffuse large B-cell lymphoma: correlation between FDG-PET uptake and type of cellular infiltrate.

机译:骨髓累及弥漫性大B细胞淋巴瘤:FDG-PET摄取与细胞浸润类型之间的相关性。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To assess, in patients with diffuse large B-cell lymphoma (DLBCL), whether the low sensitivity of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) for bone marrow assessment may be explained by histological characteristics of the cellular infiltrate. METHODS: From a prospective cohort of 110 patients with newly diagnosed aggressive lymphoma, 21 patients with DLBCL had bone marrow involvement. Pretherapeutic FDG-PET images were interpreted visually and semiquantitatively, then correlated with the type of cellular infiltrate and known prognostic factors. RESULTS: Of these 21 patients, 7 (33%) had lymphoid infiltrates with a prominent component of large transformed lymphoid cells (concordant bone marrow involvement, CBMI) and 14 (67%) had lymphoid infiltrates composed of small cells (discordant bone marrow involvement, DBMI). Only 10 patients (48%) had abnormal bone marrow FDG uptake, 6 of the 7 with CBMI and 4 of the 14 with DBMI. Therefore, FDG-PET positivity in the bone marrow was significantly associated with CBMI, while FDG-PET negativity was associated with DBMI (Fisher's exact test, p=0.024). There were no significant differences in gender, age and overall survival between patients with CBMI and DBMI, while the international prognostic index was significantly higher in patients with CBMI. CONCLUSION: Our study suggests that in patients with DLBCL with bone marrow involvement bone marrow FDG uptake depends on two types of infiltrate, comprising small (DBMI) or large (CBMI) cells. This may explain the apparent low sensitivity of FDG-PET previously reported for detecting bone marrow involvement.
机译:目的:评估弥漫性大B细胞淋巴瘤(DLBCL)患者,是否可以通过细胞的组织学特征解释(18)F-氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)对骨髓评估的敏感性低浸润。方法:从110例新诊断为侵袭性淋巴瘤的患者的前瞻性队列中,有21例DLBCL患者患有骨髓。对治疗前的FDG-PET图像进行视觉和半定量解释,然后与细胞浸润的类型和已知的预后因素相关。结果:在这21例患者中,7例(33%)淋巴样浸润具有较大的转化淋巴细胞样成分(一致的骨髓受累,CBMI),14例(67%)淋巴样浸润由小细胞组成(不协调的骨髓累及,DBMI)。只有10名患者(48%)的骨髓FDG摄取异常,CBMI 7例中有6例,DBMI 14例中有4例。因此,骨髓中FDG-PET阳性与CBMI显着相关,而FDG-PET阴性与DBMI相关(Fisher精确检验,p = 0.024)。 CBMI和DBMI患者在性别,年龄和总生存率方面无显着差异,而CBMI患者的国际预后指标则更高。结论:我们的研究表明,DLBCL伴有骨髓累及的患者,骨髓FDG的摄取取决于两种浸润类型,包括小细胞(DBMI)或大细胞(CBMI)。这可能解释了先前报道的FDG-PET在检测骨髓受累方面明显的低敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号